myostatinShop 50% off

Topic

Myostatin Science

What myostatin (GDF-8) is, how it limits muscle growth, and the inhibitor classes that target it — the foundational explainers.

63 articles

Retatrutide Cycle: Cycling, and the Anabolic Question cover
Aug 13, 20267 min read

Retatrutide Cycle: Cycling, and the Anabolic Question

Cycling solves a problem this drug does not have, and ignores the one it does. Stopping is not a rest period here, it is the start of regain.

What Is Retatrutide? What It Is, and What It Is Not cover
Aug 11, 20267 min read

What Is Retatrutide? What It Is, and What It Is Not

It is the one compound in this category with a large randomised trial behind it. That makes describing it accurately more important, not less.

Retatrutide Before And After: What Changes, and What Does Not cover
Aug 9, 20268 min read

Retatrutide Before And After: What Changes, and What Does Not

The change is real and it is visible. Whether it is the change a lifter wants is a question no photograph has ever been able to answer.

Retatrutide Side Effects: Risks Worth Knowing Before Training cover
Aug 7, 20267 min read

Retatrutide Side Effects: Risks Worth Knowing Before Training

The adverse event list is the easy part. The effect that costs a lifter most does not appear on it, because it is the drug working as intended.

Bacteriostatic Water: The Diluent Every Peptide Vial Needs cover
Aug 5, 20268 min read

Bacteriostatic Water: The Diluent Every Peptide Vial Needs

Bacteriostatic water is sterile water with a benzyl alcohol preservative, and it is the reason a reconstituted vial survives more than one entry. Here is what the label actually specifies.

Retatrutide Benefits: What It Means for Ageing Muscle cover
Aug 5, 20268 min read

Retatrutide Benefits: What It Means for Ageing Muscle

One benefit here is properly evidenced in people. The interesting question for a lifter is not whether it works, but what the working costs.

Retatrutide Protocol: What the Studies Ran, and On What cover
Aug 3, 20267 min read

Retatrutide Protocol: What the Studies Ran, and On What

The word means two different things, and only one of them has ever been written down for this compound. The difference is most of the safety and all of the monitoring.

Retatrutide Dosage: Dosing, and What It Means for Lean Mass cover
Aug 1, 20268 min read

Retatrutide Dosage: Dosing, and What It Means for Lean Mass

The trial produced a real number in real humans. For anyone who lifts, the dose that produced it is also the dose with the largest body composition bill attached.

Epithalon Cycle: Cycling, and the Anabolic Question cover
Jul 30, 20268 min read

Epithalon Cycle: Cycling, and the Anabolic Question

Cycling solves problems that steroids create and this compound does not. What is left is a schedule nobody tested, attached to an outcome nobody measured.

What Is Epithalon? What It Is, and What It Is Not cover
Jul 28, 20267 min read

What Is Epithalon? What It Is, and What It Is Not

A short definition, an honest account of a literature that comes almost entirely from one research group, and the reason telomere claims say nothing about muscle.

Epithalon Before And After: What Changes, and What Does Not cover
Jul 26, 20267 min read

Epithalon Before And After: What Changes, and What Does Not

Biological age tests have become the after picture for this compound. Here is what those numbers can detect, what moves them anyway, and why muscle is absent entirely.

Epithalon Side Effects: Risks Worth Knowing Before Training cover
Jul 24, 20267 min read

Epithalon Side Effects: Risks Worth Knowing Before Training

An unapproved compound with a concentrated literature has no adverse event database behind it. Here is what that means, and where the real hazards actually sit.

Epithalon Benefits: What It Means for Ageing Muscle cover
Jul 22, 20268 min read

Epithalon Benefits: What It Means for Ageing Muscle

The claim list, who produced it, and the specific reason cellular ageing findings say nothing about the muscle a lifter is trying to keep.

Epithalon Protocol: What the Studies Ran, and On What cover
Jul 20, 20267 min read

Epithalon Protocol: What the Studies Ran, and On What

The designs behind the claims, laid out by organism and endpoint, and the reason a concentrated literature cannot be read the same way a replicated one can.

Epithalon Dosage: Dosing, and What It Means for Lean Mass cover
Jul 18, 20267 min read

Epithalon Dosage: Dosing, and What It Means for Lean Mass

Why the numbers look so precise, why an extract and a tetrapeptide cannot share a figure, and why no amount can be aimed at muscle that has never been measured.

Semax Cycle: Cycling, and the Anabolic Question cover
Jul 16, 20267 min read

Semax Cycle: Cycling, and the Anabolic Question

Cycling exists because steroids suppress something. This compound has no suppression to recover from and no anabolic effect to preserve, which changes the question entirely.

What Is Semax? What It Is, and What It Is Not cover
Jul 14, 20267 min read

What Is Semax? What It Is, and What It Is Not

A short definition, an honest account of the Russian clinical record a Western reader cannot inspect, and a flat statement that no organism has been measured for muscle after taking it.

Semax Before And After: What Changes, and What Does Not cover
Jul 12, 20267 min read

Semax Before And After: What Changes, and What Does Not

Two different things get called a result here, and only one of them is even in principle checkable. Neither has ever been recorded in a controlled study of this compound.

Semax Side Effects: Risks Worth Knowing Before Training cover
Jul 10, 20267 min read

Semax Side Effects: Risks Worth Knowing Before Training

Why an unfamiliar safety record reads as a reassuring one, where the real risks sit for someone buying outside Russia, and what training hard adds to the picture.

Semax Benefits: What It Means for Ageing Muscle cover
Jul 8, 20267 min read

Semax Benefits: What It Means for Ageing Muscle

The benefit list is real and it is entirely about the brain. The only route from there to body composition is an untested hypothesis, and this article says exactly where it stops.

Semax Protocol: What the Studies Ran, and On What cover
Jul 6, 20267 min read

Semax Protocol: What the Studies Ran, and On What

The study designs laid out by organism and endpoint, the two protocol families that exist, and the measurement none of them ever took.

Semax Dosage: Dosing, and What It Means for Lean Mass cover
Jul 4, 20267 min read

Semax Dosage: Dosing, and What It Means for Lean Mass

Where the numbers actually originate, why the nasal route makes most conversions meaningless, and why no dose can be aimed at lean mass when no study has measured it.

Selank Cycle: Cycling, and the Anabolic Question cover
Jul 2, 20267 min read

Selank Cycle: Cycling, and the Anabolic Question

Cycling language was borrowed from steroid practice and attached to an anxiolytic. What exists instead is a course of treatment, for a condition, in one country.

What Is Selank? What It Is, and What It Is Not cover
Jun 30, 20267 min read

What Is Selank? What It Is, and What It Is Not

A registered anxiety medicine in one country, a research chemical everywhere else, and a compound with no body composition data in any species.

Selank Before And After: What Changes, and What Does Not cover
Jun 28, 20267 min read

Selank Before And After: What Changes, and What Does Not

Everything people report changing here is subjective. No study in any species has measured muscle, strength or body fat after this peptide, and that is not an oversight.

Selank Side Effects: Risks Worth Knowing Before Training cover
Jun 26, 20268 min read

Selank Side Effects: Risks Worth Knowing Before Training

A registered medicine in one country and an unverified research chemical everywhere else. The safety question changes completely depending on which one is in the vial.

Selank Benefits: What It Means for Ageing Muscle cover
Jun 24, 20267 min read

Selank Benefits: What It Means for Ageing Muscle

The studied benefits are about anxiety, not muscle. The only honest connection to body composition runs through training consistency, and even that has never been tested.

Selank Protocol: What the Studies Ran, and On What cover
Jun 22, 20267 min read

Selank Protocol: What the Studies Ran, and On What

A registry search for this peptide returns studies about epilepsy drugs and neurofeedback. Reading the records instead of counting them leaves no Western trial at all.

Selank Dosage: Dosing, and What It Means for Lean Mass cover
Jun 20, 20267 min read

Selank Dosage: Dosing, and What It Means for Lean Mass

This is one of the few research peptides with a real dose defined somewhere. That dose belongs to a prescribed medicine for anxiety, not to a vial bought online.

NAD+ Cycle: Cycling, and the Anabolic Question cover
Jun 18, 20267 min read

NAD+ Cycle: Cycling, and the Anabolic Question

The word describes a genuine biochemical cycle and a borrowed dosing habit. Untangling them removes most of the question.

What Is NAD+? What It Is, and What It Is Not cover
Jun 16, 20268 min read

What Is NAD+? What It Is, and What It Is Not

It is one of the most important molecules in human metabolism, and almost none of the human research is about the version sold in a vial.

NAD+ Before And After: What Changes, and What Does Not cover
Jun 14, 20267 min read

NAD+ Before And After: What Changes, and What Does Not

There is a real before and after in this literature. It happened in a blood sample, and it did not carry through to the tissue anyone cares about.

NAD+ Side Effects: Risks Worth Knowing Before Training cover
Jun 12, 20267 min read

NAD+ Side Effects: Risks Worth Knowing Before Training

The infusion reaction is well known to anyone who has sat through one. Almost everything else here is unmeasured, because the injected form has barely been studied.

NAD+ Benefits: What It Means for Ageing Muscle cover
Jun 10, 20267 min read

NAD+ Benefits: What It Means for Ageing Muscle

The molecule genuinely matters to energy metabolism. Whether supplying more of it changes anything in an ageing muscle is a separate question, and a harder one.

NAD+ Protocol: What the Studies Ran, and On What cover
Jun 8, 20267 min read

NAD+ Protocol: What the Studies Ran, and On What

The studies people cite ran a different molecule by a different route. Sorting the three versions apart is most of the work.

NAD+ Dosage: Dosing, and What It Means for Lean Mass cover
Jun 6, 20268 min read

NAD+ Dosage: Dosing, and What It Means for Lean Mass

Almost every number attached to this compound was generated by a different molecule taken by a different route. That is the whole problem in one sentence.

MOTS-c Cycle: Cycling, and the Anabolic Question cover
Jun 4, 202610 min read

MOTS-c Cycle: Cycling, and the Anabolic Question

Cycle lengths for this peptide were imported from anabolic steroid culture, not derived from any study. The anabolic question has a short answer: nothing has ever measured it.

What Is MOTS-c? What It Is, and What It Is Not cover
Jun 2, 20269 min read

What Is MOTS-c? What It Is, and What It Is Not

A peptide written into the mitochondrial genome, studied for fuel handling rather than growth. The identity confusion around it is worth clearing up first.

MOTS-c Before And After: What Changes, and What Does Not cover
May 31, 202610 min read

MOTS-c Before And After: What Changes, and What Does Not

Every transformation post for this peptide is uncontrolled personal reporting. The controlled study that could settle any of it has never been run by anybody.

MOTS-c Side Effects: Risks Worth Knowing Before Training cover
May 29, 20269 min read

MOTS-c Side Effects: Risks Worth Knowing Before Training

No published human trial has reported a safety profile for this peptide. The risks worth taking seriously are as much about the supply chain as the molecule.

MOTS-c Benefits: What It Means for Ageing Muscle cover
May 27, 20269 min read

MOTS-c Benefits: What It Means for Ageing Muscle

The reported benefits are about fuel handling, not growth. That distinction decides whether the compound is worth a lifter's attention or simply mislabelled.

MOTS-c Protocol: What the Studies Ran, and On What cover
May 25, 20269 min read

MOTS-c Protocol: What the Studies Ran, and On What

The protocols that exist were built to answer metabolic questions in rodents. Not one of them used muscle mass, strength or training capacity as an outcome.

MOTS-c Dosage: Dosing, and What It Means for Lean Mass cover
May 23, 20269 min read

MOTS-c Dosage: Dosing, and What It Means for Lean Mass

The dose ranges circulating for this peptide were never established in a person. Tracing where each number came from explains why nobody can convert them.

BPC-157 Cycle: Cycling, and the Anabolic Question cover
May 21, 20267 min read

BPC-157 Cycle: Cycling, and the Anabolic Question

Cycling exists because certain drugs suppress hormones and lose effect with continuous use. Neither has been shown for this peptide, which changes what the question is actually asking.

What Is BPC-157? What It Is, and What It Is Not cover
May 19, 20268 min read

What Is BPC-157? What It Is, and What It Is Not

A short definition, then the boundaries. This peptide belongs to the repair literature, not the growth literature, and the difference decides how a lifter should read every claim about it.

Trichostatin A and Myostatin: Why This HDAC Inhibitor Raises Myostatin, Not Lowers It cover
May 18, 20268 min read

Trichostatin A and Myostatin: Why This HDAC Inhibitor Raises Myostatin, Not Lowers It

Trichostatin A and myostatin tell a counter-intuitive story: TSA, a popular HDAC inhibitor, transcriptionally activates myostatin in muscle cells.

YK-11: Does the \"Myostatin SARM\" Actually Inhibit Myostatin? cover
May 18, 20269 min read

YK-11: Does the \"Myostatin SARM\" Actually Inhibit Myostatin?

YK-11 is sold as a myostatin-inhibiting SARM, but the chemistry, the source study, and the side-effect record tell a different story. Here is what the evidence really shows.

BPC-157 Before And After: What Changes, and What Does Not cover
May 17, 20267 min read

BPC-157 Before And After: What Changes, and What Does Not

The reported outcomes for this peptide happen inside connective tissue, where a camera cannot reach. That mismatch explains why the before and after genre is misleading here.

BPC-157 Side Effects: Risks Worth Knowing Before Training cover
May 15, 20267 min read

BPC-157 Side Effects: Risks Worth Knowing Before Training

A short list of reported effects is not the same as a good safety profile. Here is what the animal record covers, what nobody has measured in humans, and where the practical danger actually sits.

BPC-157 Benefits: What It Means for Ageing Muscle cover
May 13, 20267 min read

BPC-157 Benefits: What It Means for Ageing Muscle

The reported benefits are healing outcomes in animals. None of them is hypertrophy. That distinction decides whether this compound is interesting to a lifter or simply oversold.

BPC-157 Protocol: What the Studies Ran, and On What cover
May 11, 20268 min read

BPC-157 Protocol: What the Studies Ran, and On What

The word protocol means something different in a laboratory than it does in a forum thread. This is what the published procedures involved, which species ran them, and what they were built to detect.

CRISPR and Myostatin: Gene Editing, Muscle Growth, and Bodybuilding Claims cover
May 10, 20268 min read

CRISPR and Myostatin: Gene Editing, Muscle Growth, and Bodybuilding Claims

CRISPR myostatin editing is real in cells, animals, embryos, and research models, but bodybuilding biohacking claims skip the hardest safety, ethics, delivery, and legal questions.

Are Myostatin Inhibitors Legal? Supplements, Peptides, and Prescription Drugs cover
May 10, 20268 min read

Are Myostatin Inhibitors Legal? Supplements, Peptides, and Prescription Drugs

Myostatin inhibitor legality depends on the product type, intended use, sport rules, and country. This guide explains supplements, research peptides, SARMs, antibodies, prescriptions, and WADA risk.

Myostatin Protein Explained: GDF-8, Signaling, and Muscle Regulation cover
May 10, 20268 min read

Myostatin Protein Explained: GDF-8, Signaling, and Muscle Regulation

Myostatin protein, also called GDF-8, is a muscle-made signaling protein that limits muscle growth. This guide explains its structure, activation, receptors, testing, and why claims get exaggerated.

Low Myostatin: Causes, Genetics, Symptoms, and Muscle Growth cover
May 9, 20268 min read

Low Myostatin: Causes, Genetics, Symptoms, and Muscle Growth

Low myostatin can mean rare MSTN genetics, temporary blood-test changes, illness-related shifts, or marketing language. This guide explains what low myostatin does and does not prove.

Myostatin Inhibitor Reddit Claims: What Users Get Right and Wrong cover
May 9, 20268 min read

Myostatin Inhibitor Reddit Claims: What Users Get Right and Wrong

Reddit myostatin inhibitor threads mix useful skepticism with supplement hype, peptide claims, YK11 talk, and genetics myths. This fact-check separates the claims from the evidence.

BPC-157 Dosage: Dosing, and What It Means for Lean Mass cover
May 9, 20268 min read

BPC-157 Dosage: Dosing, and What It Means for Lean Mass

Every published dosing figure for this peptide belongs to a rat healing model. Here is what those numbers measured, what they did not, and why body composition sits outside the evidence entirely.

Myostatin Inhibitor Before and After: What Results Are Realistic? cover
May 7, 20269 min read

Myostatin Inhibitor Before and After: What Results Are Realistic?

Myostatin inhibitor before-and-after claims often exaggerate visible transformation. This guide explains realistic timelines, body-composition data, clinical results, and red flags.

Myostatin Inhibitor Peptides: Research, Mechanisms, and Safety Questions cover
May 7, 20269 min read

Myostatin Inhibitor Peptides: Research, Mechanisms, and Safety Questions

Myostatin inhibitor peptide claims mix real research, discontinued biologics, follistatin-style products, and online vial marketing. This guide separates mechanisms, evidence, and safety limits.

Myostatin Inhibitors in Humans: What Studies Show and What They Do Not cover
May 5, 20269 min read

Myostatin Inhibitors in Humans: What Studies Show and What They Do Not

Myostatin inhibitors in humans can increase lean mass or change body composition, but functional results are mixed. This evidence review explains the major studies and current candidates.

Myostatin Blocker Claims: What Counts as Real? cover
May 1, 20265 min read

Myostatin Blocker Claims: What Counts as Real?

A myostatin blocker is only useful if it changes the pathway and improves real outcomes. Here is what counts, what is indirect, and what is marketing.

What Is Myostatin? Function, Muscle Growth, and Why It Matters cover
May 1, 20266 min read

What Is Myostatin? Function, Muscle Growth, and Why It Matters

Myostatin is the body’s muscle-growth brake. Here is what it does, why low myostatin matters, and where the claims get ahead of the evidence.

Myostatin Inhibitors: Drugs, Supplements, Natural Options, and Evidence cover
May 1, 20267 min read

Myostatin Inhibitors: Drugs, Supplements, Natural Options, and Evidence

Myostatin inhibitors range from clinical antibodies to supplement claims. This evidence-first guide separates drugs, natural options, peptides, and hype.